RESEARCH-USE BIOSIMILAR ANTIBODY
Lumiliximab
Monoclonal antibody · IgG1
Lumiliximab (Anti-CD23 Recombinant Antibody) is an anti-CD23 monoclonal antibody that inhibits allergen-induced responses.
TARGETCD23
YMonoclonal antibody
CATALOGSC-BS-407
CATALOG NUMBERSC-BS-407
MOLECULAR WEIGHTApprox. 144.82 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Lumiliximab (Anti-CD23 Recombinant Antibody) is an anti-CD23 monoclonal antibody that inhibits allergen-induced responses.
Lumiliximab is a recombinant research-use antibody directed against CD23.